Type 1 diabetes trials in Australia

In Australia 16 Also abroad 539

16 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Where
Adelaide, Box Hill, Brisbane, Melbourne, Parkville, Perth, Randwick, Westmead
Age
1 year to 35 years
People
150 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07222137 · EU 2025-521797-34-00
Phase 3Taking people
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Where
Adelaide, Heidelberg West, Ipswich, Melbourne, Oaklands Park, Parkville, Perth, Randwick, Westmead
Age
1 year to 35 years
People
300 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07222332 · EU 2025-522170-36-00
No phaseTaking people
Closed Loop and Education for Hypoglycemia Awareness Restoration
Where
Fitzroy
Age
18 years to 75 years
People
324 worldwide
Run by
Milton S. Hershey Medical Center
See details and how to joinNCT06325202
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Where
Botany, Camberwell, Charlestown, St Albans, St Leonards, Waitara
Age
18 years and over
People
2,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00
No phaseEnrolling by invitation
Multicenter Assessment of the Pancreas in Type 1 Diabetes
Where
Melbourne
Age
8 years and over
People
250 worldwide
Run by
Vanderbilt University Medical Center
See details and how to joinNCT03585153
Phase 3Taking people
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Where
Adelaide, Brisbane, Perth
Age
1 year to 25 years
People
723 worldwide
Run by
Sanofi
See details and how to joinNCT07088068
Phase 2Taking people
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Where
Brisbane, Nedlands, Parkville, St Leonards, Westmead
Age
5 years to 40 years
People
159 worldwide
Run by
SAb Biotherapeutics, Inc.
See details and how to joinNCT07187531 · EU 2025-521560-36-00
Phase 1/2Taking people
VV-14299 and VV-14300 for the Treatment of Type 1 Diabetes
Where
Melbourne
Age
18 years to 65 years
People
29
Run by
Kriya Therapeutics, Inc.
See details and how to joinNCT07829302
Phase 3Taking people
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Where
Birtinya, Camberwell, Campbelltown, Gosford, Liverpool, Merewether, South Brisbane
Age
18 years and over
People
2,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00
Phase 2Taking people
Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes
Where
Sydney
Age
18 years to 70 years
People
44
Run by
Victor Chang Cardiac Research Institute
See details and how to joinNCT06820281
Phase 1/2Taking people
A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes Mellitus
Where
Morayfield, Nedlands
Age
18 years to 65 years
People
150 worldwide
Run by
Arrowhead Pharmaceuticals
See details and how to joinNCT06937203
Phase 1Taking people
Safety, Pharmacokinetics, and Pharmacodynamics of MTX-101 in Healthy Adults and Patients
Where
Fitzroy, Heidelberg, Melbourne
Age
18 years to 65 years
People
96
Run by
Mozart Therapeutics Australia Pty Ltd
See details and how to joinNCT06324604
Phase 2Not yet taking people in Australia
Evaluating Safe Ketone Thresholds To Minimise Ketosis in People With Type 1 Diabetes Using Dapagliflozin
Where
Fitzroy, Heidelberg, Melbourne, Parkville
Age
24 years to 85 years
People
115
Run by
St Vincent's Hospital Melbourne
See details and how to joinNCT07225465
Phase 1Not yet taking people in Australia
A Research Study to Evaluate BLX-7006 in Healthy Adults
Where
Brisbane
Age
18 years to 65 years
People
76
Run by
Biolexis Therapeutics
See details and how to joinNCT07140055
No phaseTaking people
TrialNet Pathway to Prevention of T1D
Where
Parkville
Age
2 years to 45 years
People
75,000 worldwide
Run by
University of South Florida
See details and how to joinNCT00097292
No phaseEnrolling by invitation
Transition of Care in Type 1 Diabetes Mellitus
Where
Sydney
Age
16 years and over
People
80
Run by
Northern Sydney and Central Coast Area Health Service
See details and how to joinNCT06113588